Advocates urge South Africa to reopen antitrust probe into Vertex Pharmaceuticals

What's new in pharma

August 8, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Charles Krupa/AP STAT+ | Advocates urge South Africa to reopen antitrust probe into Vertex Pharmaceuticals Vertex maintains its drug is covered by 13 health care providers in South Africa, benefiting most private and public health sector patients. By Ed Silverman Closing a zombie biotech, and Lilly's disappointing obesity readout STAT reporters talk with Natalie Holles about the decision by her company, Third Harmonic Bio, to shutter and what lessons can be learned. By Adam Feuerstein, Elaine Chen, and Allison DeAngelis STAT+ | Kennedy's rejection of mRNA vaccines thwarts scientific progress — and threatens national security, experts say Canceled development of messenger RNA vaccines imperils the country's capacity to quickly respond to a bioterror threat or new emerging pandemic. By Helen Branswell Scott Olson/Getty Images STAT+ | Eli Lilly's key obesity pill falls short of rivals, but the company still beat on earnings Today's biotech news includes Sarepta hiring Trump-linked lobbying firm, Exact buying rights to Freenome colon cancer test, etc. By Meghana Keshavan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser